Up and down the ladder: The latest comings and goings
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
FDA will host a listening session in June as part of broader work to optimize the use of, and processes, for advisory committees.
The FDA nod means trial sponsors can use Apple Watch’s A-fib history as a secondary endpoint in trials without having to do additional work.
The immense potential benefits of biotechnology are profoundly vulnerable to misuse. Better screening of synthetic DNA orders is a key barrier to bad actors.
A boy with Duchenne muscular dystrophy died after receiving a Pfizer experimental gene therapy. The company is pausing its trial in older boys.
A boy with Duchenne muscular dystrophy died after receiving a Pfizer experimental gene therapy. The company is pausing its trial in older boys.
Nominate a 2024 STAT Wunderkind STAT Wunderkinds is a chance to celebrate early-career researchers who are not yet independent scientists or program
Food as medicine has gained momentum as a strategy to improve health and well-being. It’s time to elevate physical activity as medicine to the same…
A House proposal includes extension of more flexible rules for telehealth and hospital home-care programs. To pay for it, it seeks new limits on pharmacy…
“We’ve sort of anthropomorphized AI and said it has to be a thing that’s going to replace a human. Why are we not reenvisioning that…
Dairy farmers’ reluctance to report H5N1 infections among cows or allow testing of their workers is complicating the public health response to the bird flu.